Article

Improvement of cellular stress response on resveratrol in liposomes

Department of Pharmacy, University of Ljubljana, Askerceva7, Ljubljana 1000, Slovenia.
European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V (Impact Factor: 3.38). 07/2009; 73(2):253-9. DOI: 10.1016/j.ejpb.2009.06.006
Source: PubMed

ABSTRACT

Resveratrol (RSV) has proven potential in prophylaxis and treatment of various disorders mediated by free radicals and oxidative stress. RSV solubility, stability, and cytotoxicity must be regulated for satisfactory bioavailability. Here, RSV was loaded into liposomes, characterized by PCS and TEM and evaluated on HEK293 cell line by metabolic activity assay, electron paramagnetic resonance, and fluorescence microscopy. RSV at 10 microM induced changes in cell metabolic activity and significantly improved antioxidative capacity. At 100 microM it showed concentration-dependent cytotoxicity. Oligolamellar liposomes with mean diameter 84 nm, polydispersity index 0.2, and zeta potential -40 mV showed high entrapment of RSV and rapid cellular internalization. Cell stress caused by UV-B irradiation diminished cell metabolic activity by 50%. RSV loaded into them showed no cytotoxicity at 100 microM and stimulated cellular metabolic and antioxidant activity levels to eliminate the harmful effect of the stress. Localization of RSV within liposomal bilayer is crucial for stimulation of cell-defense system, prevention of RSV cytotoxicity, and its long-term stability. In summary, evidence of different metabolic activity using free RSV and LIP-RSV is presented indicating that liposome-mediated uptake of RSV is more effective for improvement of the cell-stress response.

Download full-text

Full-text

Available from: Marjeta Sentjurc
    • "Resveratrol has been incorporated into liposomes and the efficacy of the system was demonstrated by evaluating its capacity of protecting human-derived renal epithelial cells (HEK293) from free radical damage, when compared with resveratrol. Some concluding remarks have been highlighted: no cytotoxicity (at 100 μM) has been detected for resveratrol/liposome system and its efficacy in protecting cells from free radical damage[162]. A successful development of resveratrol encapsulated in polymeric micelles lead to the protection of PC12 cells, a cell line derived from a pheochromocytoma of the rat adrenal medulla, against A-induced damage by attenuating oxidative stress and affecting the apoptosis without long-term cytotoxicity . "
    [Show abstract] [Hide abstract]
    ABSTRACT: The efficacy, cellular uptake and specific transport of dietary antioxidants to target organs, tissues and cells remains the most important setback for their application in the treatment of oxidative-stress related disorders and in particular in neurodegenerative diseases, as brain targeting remains a still unsolved challenge. Nanotechnology based delivery systems can be a solution for the above mentioned problems, specifically in the case of targeting dietary antioxidants with neuroprotective activity. Nanotechnology-based delivery systems can protect antioxidants from degradation, improve their physicochemical drug-like properties and in turn their bioavailability. The impact of nanomedicine in the improvement of the performance of dietary antioxidants, as protective agents in oxidative-stress events, specifically through the use of drug delivery systems, is highlighted in this review as well as the type of nanomaterials regularly used for drug delivery purposes. From the data one can conclude that the research combining (dietary) antioxidants and nanotechnology, namely as a therapeutic solution for neurodegenerative diseases, is still in a very early stage. So, a huge research area remains to be explored that hopefully will yield new and effective neuroprotective therapeutic agents in a foreseeable future.
    No preview · Article · Sep 2014 · Current Medicinal Chemistry
  • Source
    • "Polyphenolic compounds are widely distributed in medicinal plants, vegetables, fruit and have received considerable attention during the past years as they possess many beneficial effects on human health (Caddeo et al., 2008; Sinico et al., 2008; Kristl et al., 2009; Caddeo et al., 2013). In particular, quercetin (QUE; 3,3 0 ,4 0 ,5,7-pentahydroxyflavone) has been demonstrated to exert strong antioxidant and anti-inflammatory activities against osteoporosis, certain forms of cancer, pulmonary and cardiovascular diseases and aging (Boots et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Context: Quercetin (QUE) is a flavonoid with antioxidant/anti-inflammatory properties, poorly absorbed when orally administered. Objectives: To prepare chitosan/xanthan gum microparticles to increase QUE oral bioavailability and optimize its release in the colon. Materials and methods: Chitosan/xanthan gum hydrogel embedding QUE was spray-dried to obtain microparticles characterized by size, scanning electron microscopy, differential scanning calorimetry and X-ray diffraction. Microparticles were compressed into tablets, coated with Eudragit® to further prevent degradation in acidic pH. The swelling degree and QUE release in simulated gastric and intestinal pH were investigated. Results: Microparticles were smooth and spherical, around 5 µm, with successful QUE loading. Microparticle tablets provided resistance to acidic conditions, allowing complete drug release in alkaline pH, mimicking colonic environment. The release was controlled by non-Fickian diffusion of the dissolved drug out of the swollen polymeric tablet. Discussion and conclusion: Microparticle tablets represent a promising dosage form for QUE delivery to the colon in the oral therapy of inflammatory-based disorders.
    Full-text · Article · Jun 2014 · Journal of Microencapsulation
  • Source
    • "Results from pharmacokinetic studies indicate that the oral bioavailability of t-RVT is almost zero, which casts doubt on the physiological relevance of the high concentrations typically used for in vitro experiments [6]. However, its hydrosolubility of 3 mg/100 mL [10] [11] [12] makes it " practically insoluble " in water according to the European Pharmacopeia definition, and its log P is 3.1 [13]. Despite this poor water solubility , t-RVT exhibits high membrane permeability and can be considered a Class-II compound in the Biopharmaceutical Classification System [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A rapid reversed-phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of trans-resveratrol (t-RVT) in PLGA nanoparticle formulation. A new formulation of t-RVT loaded PLGA nanoparticles (NPs) with potential stealth properties was prepared by nanoprecipitation method in our laboratory. The desired chromatographic separation was achieved on a Phenomenex C18 column under isocratic conditions using UV detection at 306 nm. The optimized mobile phase consisted of a mixture of methanol: 10 mM potassium dihydrogen phosphate buffer (pH 6.8): acetonitrile (63 : 30 : 7, v/v/v) at a flow rate of 1 mL/min. The linear regression analysis for the calibration curves showed a good linear correlation over the concentration range of 0.025–2.0 μg/ml, with determination coefficients, R2, exceeding 0.9997. The method was shown to be specific, precise at the intraday and interday levels, as reflected by the relative standard deviation (RSD) values, lower than 5.0%, and accurate with bias not exceeding 15% and percentage recovery was found to be in the range between 94.5 and 101.2. The limits of detection and quantification were 0.002 and 0.007 μg/ml, respectively. The method was successfully applied for the determination of t-RVT encapsulation efficiency.
    Full-text · Article · Feb 2014
Show more